Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization.
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety of parathyroid hormone in combination
with G-CSF when used as a stem cell mobilization regimen for patients who fail to mobilize
sufficient progenitor stem cells after one or two attempts.
Phase:
Phase 1
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborators:
Beth Israel Deaconess Medical Center Dana-Farber Cancer Institute